Title : Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.

Pub. Date : 2003 Dec

PMID : 14673984






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Tacrolimus, at dosages of both 2 mg/day and 3 mg/day, is efficacious and safe as monotherapy for patients with active RA, but treatment with the 3-mg dose of tacrolimus resulted in generally better ACR response rates. Tacrolimus acrosin Homo sapiens
2 CONCLUSION: Tacrolimus, at dosages of both 2 mg/day and 3 mg/day, is efficacious and safe as monotherapy for patients with active RA, but treatment with the 3-mg dose of tacrolimus resulted in generally better ACR response rates. Tacrolimus acrosin Homo sapiens